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Objective: SirT1 is a nuclear NAD-dependent deacetylase associated
with cellmetabolismand survival. In joints, recent evidence shows that it
regulates cartilage homeostasis and is involved in the inﬂammatory
phase of osteoarthritis (OA). It is widely held that the inﬂammatory
cytokines tumor necrosis factor alpha (TNFa), and interleukin 1b (IL-1b)
may elicit chondrocyte death associated with the deterioration of artic-
ular cartilage (AC) in OA. Exposing human chondrocytes to both cyto-
kines leads to cathepsin B-mediated cleavage of the nuclear full-length
SirT1 (FLSirT1; 110kDa) to generate a stable but enzymatically inactive
75kDa fragment of SirT1 (75SirT1). Here we aim to elucidate the bio-
logical andbiochemical role of 75kDa SirT1 fragment in-vivo and in-vitro
Methods: Using immunoblot analyses we aimed to detect cathepsin B,
FLSirT1 and/or 75SirT1 in OA and normal human chondrocytes.
Confocal imaging of SirT1 was used tomonitor its subcellular trafﬁcking
following TNFa stimulation of human chondrocytes. Coimmuno-
ﬂuorescent staining for cathepsin B, mitochondrial cytochrome oxidase
subunit IV and lysosome-associated membrane protein 1 together with
SirT1was performed. Human chondrocytes were tested for apoptosis by
ﬂuorescence-activated cell sorter analysis and immunoblotting for
caspases 3 and 8. Human chondrocyte mitochondrial extracts were
obtained and analyzed for 75SirT1-cytochrome C association.
In-vivo assays of heterozygous haploinsufﬁcient (SirT1+/-) and wild-
type (WT; SirT1+/+) 129/J mice aged 1 or 9 months were systematically
compared for musculoskeletal features, scored for osteoarthritis (OA)
severity, and monitored for chondrocyte apoptosis in articular cartilage.
Protein extracts from articular chondrocytes were isolated and immu-
noblotted for SirT1 and active caspase 3.
Results: Confocal imaging, immunoprecipitation assays and immuno-
blot analyses following TNFa challenge of human chondrocytes
exhibited that 75SirT1 was generated and exported to the cytoplasm
wherein it colocalized with the mitochondrial membrane and associ-
ates with cytochrome C. Additionally, levels of cathepsin B and 75SirT1
were elevated in OA versus normal chondrocytes. Subjecting human
chondrocytes to TNFa and a cathepsin B inhibitor (ALLN), enhanced
levels of apoptotic cell and cleaved caspase 3.
Immunoblot assays comparing medial tibial plateau articular cartilage
(MTP-AC) of heterozygous haploinsufﬁcient (SirT1+/-) and wild-type
(WT; SirT1+/+) 129/J mice revealed reduced levels of FLSirT1 in both
strains at 9 months compared to their 1 month equivalent. WT 9-month-
old strains presented the 75SirT1 fragments in immunoblot assays,
whereas age-matched SirT1+/-mice possessed undetected 75SirT1 levels.
Interestingly, 9 month-old SirT1+/- mice exhibited increased OA severity
andaugmented levels of apoptosis comparedwithage-matchedWTmice.
Conclusion: Despite 75SirT1 being enzymatically impaired our results
show that it is relatively stable and participates in promoting chon-
drocyte survival following exposure to proinﬂammatory cytokines or
during articular cartilage maturation.80
ASYMPTOMATIC INDIVIDUALS WITH RADIOGRAPHIC EVIDENCE OF
KNEE OSTEOARTHRITIS WALK WITH DIFFERENT KNEE MECHANICS
PATTERNS THAN SYMPTOMATIC INDIVIDUALS WITH THE SAME
RADIOGRAPHIC EVIDENCE
J.L. Astephen Wilson, G. Hatﬁeld, W.D. Stanish, C.L. Hubley-
Kozey. Dalhousie Univ., Halifax, NS, Canada
Table 1
Group mean demographics, walking speed and clinical scores.
Variable asymptomatic symptomatic P-value
N (M/F) 7/20 28/9
Age (years) 55.2 (8.6) 58.8 (8.3) 0.10
BMI (kg/m2) 26.2 (4.4) 30.8 (4.6) <0.0001
Self-selected speed (m/sec) 1.37 (0.19) 1.26 (0.2) 0.02
WOMAC Total 0.93 (2.5) 33.3 (18.3) <0.0001
WOMAC Pain 0.19 (0.6) 7.2 (15.8) <0.0001
WOMAC Stiffness 0.37 (0.9) 3.7 (1.6) <0.0001
WOMAC Function 0.37 (1.3) 22.4 (13.0) <0.0001
SF-36 Total 76.7 (4.9) 70.2 (15.8) 0.04
SF-36 Physical Health 79.8 (5.8) 59.7 (19.2) <0.0001
SF-36 Mental Health 66.2 (4.1) 79.2 (13.1) <0.0001
KL Grade Distribution (2/3) 23/4 10/27
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gait between asymptomatic individuals and symptomatic individuals
diagnosed with moderate knee OA, all with Kellgren-Lawrence (KL)
osteoarthritis (OA) radiographic grade 2 or 3.
Methods: Individuals withmoderate medial compartment knee OA and
asymptomatic adults underwent gait testing. Three-dimensional joint
angles and net external knee joint moments of the affected (OA) or
randomized (asymptomatic) knee were calculated from a synchronized
motion capture and force platform system during self-selected speed
gait. KL grades of standard anterior-posterior knee radiographs were
scored by an orthopaedic surgeon (WDS). Principal component analysis
(PCA) extracted major patterns of variability from the angle and
moment waveforms individually (i.e. 6 PCA analyses). Participant
waveforms were projected onto each principal component to calculate
a set of PC scores. Asymptomatic and symptomatic PC scores were
compared using an ANOVA.
Results: Twenty-seven asymptomatic individuals and 37 symptomatic
individuals diagnosed with moderate OA had a KL score of 2 or 3. There
were no signiﬁcant group differences in age, or in any features of the
frontal and transverse plane knee angles. The asymptomatic group
walked with a signiﬁcantly faster self-selected walking speed, had
smaller BMI, and lower WOMAC and higher SF-36 total and physical
function scores (Table 1). The only signiﬁcant kinematic difference
between the groups was in the overall magnitude of the knee ﬂexion
angle (PC1, p ¼ 0.0006), with the asymptomatic group having higher
ﬂexion angles. The asymptomatic group had lower overall magnitude of
the knee adduction moment (PC1, p <0.0001), and greater difference
between the ﬁrst peak and themid-late stance adductionmoment (PC2,
p ¼ 0.05) than the OA group. The asymptomatic group had earlier peak
extension moments prior to toe-off (PC3, p <0.0001), as well as more
constant internal rotation moment (PC1, p <0.0001) and earlier peak
rotation moments (PC3, p ¼ 0.01) during stance (Figure 2).
Conclusions: It was interesting that twenty-seven of 28 asymptomatic
individuals tested had radiographic evidence (KL 2,3) of OA in their
knee joints. Compared to the gait patterns of those diagnosed with
moderate OA with the same radiographic scores, the asymptomatic
group walked faster with higher overall knee ﬂexion angles, earlier
peak extension moments, lower and less constant knee adduction
moment loading and more constant knee rotation moment loading
during gait. The lower overall adduction moment would suggest that
high adduction moments may be a symptomatic feature of OA and not
an early mechanism of OA development. The sagittal and frontal plane
pattern differences have been previously associated with higher
walking speeds and may be a reﬂection of a less symptomatic joint. The
altered rotation moment pattern difference is not speed or function
related according to previous study and may support hypotheses that
altered rotational joint mechanics is a factor in early knee OA devel-
opment, prior to the onset of symptoms.
ĂĂ81
BASELINE BONE MARROW LESION VOLUME AND BONE MARROW
LESION REGRESSION ARE ASSOCIATEDWITH KNEE OSTEOARTHRITIS
PROGRESSION: DATA FROM THE OSTEOARTHRITIS INITIATIVE
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Purpose: Investigators have hypothesized that reducing bone marrow
lesion (BML) size (BML regression) may be an important therapeutic
goal for modifying osteoarthritis (OA) progression. However, it is
unclear if BML regression is associated with less joint degeneration. We
aimed to evaluate if decreased BML volume was associated with less
joint degeneration (joint space narrowing [JSN] and articular cartilage
loss).
Methods:We evaluated two samples, the Osteoarthritis Initiative (OAI)
and a clinical trial of vitamin D among patients with knee OA. The OAI
sample comprised 404 individuals with magnetic resonance images
(MRI) at the 24- and 48-month visits. The right knee was assessed
unless contraindicated. Two raters used a semi-automated segmenta-
tion method to determine BML volume on sagittal fat-suppressed
MRI(ICC¼ 0.59 - 0.93). BML volumewas the sum of the BML volumes in
the index tibiofemoral (TF) compartment (medial compartment unless
the lateral compartment had greater JSN). BML volume change was
classiﬁed into quartiles. We chose the middle two quartiles of BML
volume change as the reference group. At the 24- and 48-month visits
weight-bearing ﬁxed-ﬂexion knee radiographs were acquired and
